JANE STREET GROUP, LLC - REDHILL BIOPHARMA LTD ownership

REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 67 filers reported holding REDHILL BIOPHARMA LTD in Q1 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of REDHILL BIOPHARMA LTD
ValueSharesWeighting
Q4 2022$2,015
-77.6%
14,364
+33.4%
0.00%
Q2 2022$9,000
-90.9%
10,770
-72.4%
0.00%
Q1 2022$99,000
-56.8%
39,075
-56.7%
0.00%
Q4 2021$229,000
-78.1%
90,276
-60.5%
0.00%
Q3 2021$1,044,000
+635.2%
228,399
+1002.0%
0.00%
Q2 2021$142,000
+49.5%
20,725
+59.4%
0.00%
Q1 2021$95,0000.0%13,000
-38.2%
0.00%
Q1 2020$95,000
-75.3%
21,036
-64.6%
0.00%
-100.0%
Q2 2019$384,000
+39.1%
59,405
+108.1%
0.00%0.0%
Q1 2017$276,00028,5480.00%
Other shareholders
REDHILL BIOPHARMA LTD shareholders Q1 2021
NameSharesValueWeighting ↓
Ibex Investors LLC 444,301$2,284,0001.33%
683 Capital Management, LLC 999,232$5,136,0000.43%
DAFNA Capital Management LLC 35,000$180,0000.10%
MENORA MIVTACHIM HOLDINGS LTD. 421,000$2,164,0000.08%
Migdal Insurance & Financial Holdings Ltd. 397,324$2,042,0000.05%
Claret Asset Management Corp 42,522$219,0000.05%
Orbimed Advisors 564,900$2,904,0000.04%
Altshuler Shaham Ltd 169,446$251,0000.04%
Virtu Financial LLC 60,787$312,0000.02%
MEITAV INVESTMENT HOUSE LTD 48,000$244,0000.01%
View complete list of REDHILL BIOPHARMA LTD shareholders